Sign Up Today and Learn More About Excision BioTherapeutics Stock
Invest in or calculate the value of your shares in Excision BioTherapeutics or other pre-IPO companies through EquityZen's platform.
Excision BioTherapeutics Stock (EXCB)
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
About Excision BioTherapeutics Stock
Founded
2015
Headquarters
Philadelphia, PA, US
Industries
Software, Data and Analytics, Artificial Intelligence
Excision BioTherapeutics Press Mentions
Stay in the know about the latest news on Excision BioTherapeutics
Excision’s CRISPR-Based HIV Treatment Fails to Show Curative Potential in Early Study
biospace • Aug 03, 2024
Trial using CRISPR to edit HIV out of cells disappoints
statnews • Jun 04, 2024
Excision BioTherapeutics on LinkedIn: At the Annual Meeting
linkedin • May 24, 2024
Excision’s CRISPR-Based HIV Treatment Fails to Show Curative Potential in Early Study
biospace • May 24, 2024
Computer-implemented systems and methods for targeting microhomology-mediated …
patents • Apr 14, 2024
Excision BioTherapeutics Management
Leadership team at Excision BioTherapeutics
Board Member
Vasudev Bailey
Board Member
Ashok Krishnamurthi
Join now and verify your accreditation status to gain access to:
- Excision BioTherapeutics current valuation
- Excision BioTherapeutics stock price
- Available deals in Excision BioTherapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Excision BioTherapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Excision BioTherapeutics through EquityZen funds. These investments are made available by existing Excision BioTherapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Excision BioTherapeutics stock?
Shareholders can sell their Excision BioTherapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
